Catalyst Wire Dossier Catalyst Wire Dossier

Pardoprunox

pardoprunox · Abbott
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pardoprunox, covering 2011-08-26 to 2011-08-26. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia. [Phase 2]

See pricing